NCT04199260 (PAPILOBS) is a clinical trial of papilocare vaginal gel in HPV Infection, sponsored by Procare Health Iberia S.L..

Who is sponsoring NCT04199260?

NCT04199260 is sponsored by Procare Health Iberia S.L..

What drugs are being tested in NCT04199260?

Interventions in NCT04199260: papilocare vaginal gel.

What condition does NCT04199260 study?

NCT04199260 studies HPV Infection, Lesion Cervix.

Is NCT04199260 still recruiting?

NCT04199260 is currently completed. Last updated 9 August 2021.

Last reviewed 2021-08-09 · How we verify

NCT04199260: PAPILOBS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigation to Evaluate PAPILOCARE® Gel Effect on Normalization of Cervix Cytological Alterations Caused by HPV.

Completed Last updated 9 August 2021

What this trial tests

trial testing papilocare vaginal gel in HPV Infection in 263 participants. Completed in 18 February 2021.

Timeline

20 May 2018

Primary endpoint
18 February 2021

18 February 2021

Quick facts

Lead sponsor	Procare Health Iberia S.L.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	263
Start date	20 May 2018
Primary completion	18 February 2021
Estimated completion	18 February 2021
Sites	9 locations across Spain

Drugs / interventions tested

papilocare vaginal gel

Conditions studied

HPV Infection — all drugs for HPV Infection →
Lesion Cervix — all drugs for Lesion Cervix →

Sponsor

Procare Health Iberia S.L. — full company profile →

Who can join

25 and older, female only, with HPV Infection or Lesion Cervix. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Observational clinical study, national, multicentric, prospective, non-comparative, with medical device, under application consistent with CE marking, for the evaluation of Papilocare® effectivness in the normalization of cervix cytological abnormalities caused by HPV.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Efficacy of a Coriolusversicolor-Based Vaginal Gel in Human Papillomavirus-Positive Women Older Than 40 Years: A Sub-Analysis of PALOMA Study.
Gil-Antuñano SP, Serrano Cogollor L, López Díaz AC, González Rodríguez SP, et al · · 2022 · cited 9× · PMID 36294699 · DOI 10.3390/jpm12101559
Effect of a Multi-Ingredient Coriolus-versicolor-Based Vaginal Gel in Women with HPV-Dependent Cervical Lesions: The Papilobs Real-Life Prospective Study.
Cortés Bordoy J, de Santiago García J, Agenjo González M, Dexeus Carter D, et al · · 2023 · cited 4× · PMID 37568678 · DOI 10.3390/cancers15153863

Verify or expand the search:

Other recruiting trials for HPV Infection

Currently open trials in the same condition.

NCT07225530 — Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) · NA · recruiting
NCT07281677 — Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years · Phase 4 · recruiting
NCT06507917 — Concordance and Acceptability of Self-screening Versus Screening by a Healthcare Professional for HPV, a Risk Factor for · NA · recruiting
NCT07336134 — PopSci CHW4CervixHealth · NA · recruiting
NCT06959563 — Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV · EARLY_PHASE1 · active not recruiting

Other Procare Health Iberia S.L. trials

Trials by the same sponsor.

NCT06668012 — A Multicenter, Open, Comparative Study on Vaginal Dysbiosis in Premenopausal Women (DISPALOMA) · NA · recruiting
NCT05275244 — Evaluate Clinical Benefit of Local Treatment With KD Intra-Articular® Gel in Patients With Osteoarthritis (NO-DOLOR2) · completed
NCT04766957 — Pilot Clinical Trial of IDRACARE® in Moderate to Severe Symptoms of Vulvovaginal Atrophy · NA · completed
NCT04188600 — Study to Evaluate the Effectiveness and Safety of Libicare® in Women With Low Arousal and Sexual Desire Levels · NA · withdrawn
NCT04124640 — Observational Study in Real Life to Describe the Libicare® Effectiveness in Female Sexual Dysfunction. · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04199260 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Procare Health Iberia S.L.
Last refreshed: 9 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04199260.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing